These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 28432271)

  • 21. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
    Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
    Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells.
    Zhang Z; Chen L; Yang Q; Tang X; Li J; Zhang G; Wang Y; Huang H
    Int J Biochem Cell Biol; 2024 Jun; 171():106570. PubMed ID: 38588888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
    Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells.
    Cao W; Zhang B; Liu Y
    Biomed Res Int; 2022; 2022():4752782. PubMed ID: 35915794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The critical role of peroxiredoxin-2 in colon cancer stem cells.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Fu Z
    Aging (Albany NY); 2021 Mar; 13(8):11170-11187. PubMed ID: 33819194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
    Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
    Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
    Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
    Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway.
    Liu G; Zhou J; Dong M
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Luo S; Xie J
    Oncol Rep; 2017 Jan; 37(1):123-130. PubMed ID: 27878272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway.
    Chen X; Xu H; Yu X; Wang X; Zhu X; Xu X
    J BUON; 2019; 24(2):488-493. PubMed ID: 31127995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.
    Allen JE; Gallant JN; Dicker DT; Amin S; Irby RB; Sharma AK; El-Deiry WS
    PLoS One; 2013; 8(3):e59380. PubMed ID: 23555026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
    Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
    Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway.
    Xiao ZM; Wang XY; Wang AM
    Biotechnol Appl Biochem; 2015; 62(3):401-6. PubMed ID: 24372557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.
    Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H
    Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.